Intra-Cellular Therapies Inc (NAS:ITCI)
$ 75.11 -0.15 (-0.2%) Market Cap: 7.94 Bil Enterprise Value: 6.95 Bil PE Ratio: 0 PB Ratio: 6.93 GF Score: 58/100

Q3 2023 Intra-Cellular Therapies Inc Earnings Call Transcript

Nov 02, 2023 / 12:30PM GMT
Release Date Price: $52.38 (+2.97%)
Operator

Thank you for standing by, and welcome to the Intra-Cellular Therapies 3Q 2023 Earnings Conference Call. (Operator Instruction] Please be advised that today's call is being recorded.

I would like to turn the call over to your host, Dr. Juan Sanchez, Head of Investor Relations at ITCI. Please go ahead, sir.

Juan Fernando Sanchez
Intra-Cellular Therapies, Inc. - VP of Corporate Communications & IR

Good morning, and thank you all for being here. Joining me on the call today are Dr. Sharon Mates, Chairman and Chief Executive Officer; Mark Neumann, Chief Commercial Officer; Dr. Suresh Durgam, Chief Medical Officer; and Larry Hineline, Chief Financial Officer.

As a reminder, during today's call, we will be making certain forward-looking statements. These forward-looking statements are based on current information, assumptions and expectations. Those are subject to change and involve a number of risks and uncertainties that may cause actual results to differ materially from those contained in the forward-looking statements. These and other

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot